FDA Approval Activities for this Drug…

Omnipaque (iohexol) Injection, Amersham Health NDA 18-956/SLR-049 12/23/02 1/29/03 Omnipaque (iohexol) Injection, Amersham Health NDA 18-956/SLR-039 IOHEXOL Injection 30.2% OMNIPAQUE 140 AMERSHAM HLTH | 018956 IOHEXOL Solution; Injection, 75.5% OMNIPAQUE 350 AMERSHAM HLTH | 020608 IOHEXOL Solution; Injection, 75.5% OMNIPAQUE 350 AMERSHAM HLTH | 018956 IOHEXOL Solution; Injection, Rectal 38.8% OMNIPAQUE 180 AMERSHAM HLTH | 018956 IOHEXOL Solution; Injection, Rectal 51.8% OMNIPAQUE 240 AMERSHAM HLTH | 020608 IOHEXOL Solution; Injection, Rectal 51.8% OMNIPAQUE 240 AMERSHAM HLTH | 020608 IOHEXOL Solution; Injection, Rectal 64.7% OMNIPAQUE 300 AMERSHAM HLTH | 018956 IOHEXOL Solution; Injection, Rectal 64.7% OMNIPAQUE 300 AMERSHAM HLTH Omnipaque (iohexol) | Omnipaque (Iohexol) Injection, GE Healthcare, Labeling Revision Injection, Amersham Health | Omnipaque (iohexol) Injection, GE Healthcare, Manufacturing Change or Addition

For the latest approval information, please locate this drug using this index.